DE60110084D1 - Zusammensetzung, welche ein eisenkomplexierendes protein und einen vorläufer im stoffwechsel von stickstoffoxid oder einen stickstoffoxid donor enthält - Google Patents
Zusammensetzung, welche ein eisenkomplexierendes protein und einen vorläufer im stoffwechsel von stickstoffoxid oder einen stickstoffoxid donor enthältInfo
- Publication number
- DE60110084D1 DE60110084D1 DE60110084T DE60110084T DE60110084D1 DE 60110084 D1 DE60110084 D1 DE 60110084D1 DE 60110084 T DE60110084 T DE 60110084T DE 60110084 T DE60110084 T DE 60110084T DE 60110084 D1 DE60110084 D1 DE 60110084D1
- Authority
- DE
- Germany
- Prior art keywords
- nitrogen
- iron
- precursor
- composition containing
- oxidant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 title abstract 11
- 239000002243 precursor Substances 0.000 title abstract 3
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 title 4
- 229910052757 nitrogen Inorganic materials 0.000 title 2
- 239000007800 oxidant agent Substances 0.000 title 1
- 230000001590 oxidative effect Effects 0.000 title 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract 4
- 235000015872 dietary supplement Nutrition 0.000 abstract 2
- 150000002505 iron Chemical class 0.000 abstract 2
- 229910052742 iron Inorganic materials 0.000 abstract 2
- 230000004060 metabolic process Effects 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- 208000007502 anemia Diseases 0.000 abstract 1
- 206010003549 asthenia Diseases 0.000 abstract 1
- 230000000536 complexating effect Effects 0.000 abstract 1
- 239000008139 complexing agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Zoology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Obesity (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0009883A FR2812200B1 (fr) | 2000-07-27 | 2000-07-27 | Composition contenant une proteine complexant le fer et un precurseur du metabolisme du monoxyde d'azote et/ou un donneur chimique de monoxyde d'azote ; et utilisations |
| PCT/FR2001/002469 WO2002009740A1 (fr) | 2000-07-27 | 2001-07-27 | Composition contenant une proteine complexant le fer et un precurseur du metabolisme du monoxyde d'azote et/ou un donneur chimique de monoxyde d'azote et utilisations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60110084D1 true DE60110084D1 (de) | 2005-05-19 |
Family
ID=8852998
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60110084T Expired - Lifetime DE60110084D1 (de) | 2000-07-27 | 2001-07-27 | Zusammensetzung, welche ein eisenkomplexierendes protein und einen vorläufer im stoffwechsel von stickstoffoxid oder einen stickstoffoxid donor enthält |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6984624B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1303296B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2004520264A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE292978T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2001279922A1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE60110084D1 (cg-RX-API-DMAC7.html) |
| FR (1) | FR2812200B1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2002009740A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10215315A1 (de) * | 2002-04-05 | 2003-11-20 | Aventis Behring Gmbh Intellect | Human-Transferrin zur Behandlung der Anaemia of Chronic Disease (ACD) und des funktionellen Eisenmangels |
| JP2007504883A (ja) | 2003-09-12 | 2007-03-08 | オル−ニム メディカル リミテッド | 対象領域の非侵襲的光学モニタリング |
| EP1589283B1 (en) * | 2004-04-23 | 2006-08-16 | Abb Research Ltd. | Model and control of a waste combustion process |
| RU2007117147A (ru) * | 2004-10-08 | 2008-11-20 | Юнилевер Н.В. (Nl) | Комплекс железа |
| EP1867330A4 (en) * | 2005-03-30 | 2012-01-25 | Kyowa Hakko Bio Co Ltd | METHOD FOR IMPROVING THE STORAGE STABILITY OF A SUBSTANCE |
| WO2009102677A1 (en) * | 2008-02-11 | 2009-08-20 | Tabatchnick Fine Foods, Inc. | A nutritionally enhanced therapeutic preventative food supplement and method of making same |
| WO2009101789A1 (ja) * | 2008-02-14 | 2009-08-20 | Morinaga Milk Industry Co., Ltd. | 卵巣機能改善剤 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2149338T3 (es) * | 1993-11-02 | 2000-11-01 | Us Health | Utilizacion de compuestos que liberan oxido nitrico para la fabricacion de un medicamento destinado al tratamiento de lesiones por reperfusion isquemica. |
| US5827729A (en) * | 1996-04-23 | 1998-10-27 | Advanced Tissue Sciences | Diffusion gradient bioreactor and extracorporeal liver device using a three-dimensional liver tissue |
| AU6307698A (en) * | 1997-02-03 | 1998-08-25 | Pharming Bv | Useful properties of human lactoferrin and variants thereof |
-
2000
- 2000-07-27 FR FR0009883A patent/FR2812200B1/fr not_active Expired - Fee Related
-
2001
- 2001-07-27 US US10/333,554 patent/US6984624B2/en not_active Expired - Fee Related
- 2001-07-27 DE DE60110084T patent/DE60110084D1/de not_active Expired - Lifetime
- 2001-07-27 AU AU2001279922A patent/AU2001279922A1/en not_active Abandoned
- 2001-07-27 EP EP01958190A patent/EP1303296B1/fr not_active Expired - Lifetime
- 2001-07-27 WO PCT/FR2001/002469 patent/WO2002009740A1/fr not_active Ceased
- 2001-07-27 JP JP2002515293A patent/JP2004520264A/ja active Pending
- 2001-07-27 AT AT01958190T patent/ATE292978T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US20040033945A1 (en) | 2004-02-19 |
| EP1303296A1 (fr) | 2003-04-23 |
| EP1303296B1 (fr) | 2005-04-13 |
| FR2812200B1 (fr) | 2003-01-03 |
| US6984624B2 (en) | 2006-01-10 |
| ATE292978T1 (de) | 2005-04-15 |
| AU2001279922A1 (en) | 2002-02-13 |
| JP2004520264A (ja) | 2004-07-08 |
| FR2812200A1 (fr) | 2002-02-01 |
| WO2002009740A1 (fr) | 2002-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO954441D0 (no) | Tricyklopolyazamakrocyklofosfonsyrer, komplekser og derivater derav for anvendelse som kontrastmidler | |
| UA34768A (uk) | Склад для обробки пар тертя | |
| NO954440L (no) | 2 pyridylmetylenpolyazamakrocyklo-fosfonsyrer, komplekser og derivater derav, for anvendelse som kontrastmidler | |
| NO20015991D0 (no) | Bisykliske polyaminoacid-metallkomplekser, fremgangsmåter for fremstilling av disse og anvendelse i medisinsk billeddannelse | |
| EP1311269A4 (en) | PROCESS FOR USE OF DIKETOPIPERAZINES AND COMPOSITIONS THEREOF CONTAINING THEM | |
| MY136095A (en) | Use of human anti-ctla-4 antibodies for treatment of cancer | |
| ATE246197T1 (de) | Neue heteroaromatische fructose 1,6- bisphosphatase inhibitoren | |
| GR3005454T3 (cg-RX-API-DMAC7.html) | ||
| DE69914357D1 (de) | Pyridin-4-yl oder pyrimidin-4-yl substituierte pyrazine | |
| EP1053010A4 (en) | COPOLYMER COMPOSITIONS FOR ORAL ADMINISTRATION | |
| DE60110084D1 (de) | Zusammensetzung, welche ein eisenkomplexierendes protein und einen vorläufer im stoffwechsel von stickstoffoxid oder einen stickstoffoxid donor enthält | |
| ATE143266T1 (de) | Komplexe und chelate des azithromycins als antiulcus-mittel | |
| SE9802937D0 (sv) | Novel compounds | |
| BR9912547A (pt) | (poli)isocianatos ocultos mistos | |
| CA2481593A1 (en) | Biologically stable liquid composition of fviii, of vwf or of fviii/vwf complex of human origin | |
| WO1998012329A3 (en) | Composition and method for enhancing fibrinolysis using antibodies to alpha-2-antiplasmin | |
| EP1364657A4 (en) | REMEDIES AGAINST TUMORS AFFECTING HEMATOPOIETIC BODIES | |
| DE60003943D1 (de) | Trimegestone enthaltende pharmazeutische zusammensetzungen | |
| DE60311627D1 (de) | Mittel zum färben von menschlichem Keratinmaterial, enthaltend mindestens zwei Komponenten und Färbeverfahren | |
| MXPA04004304A (es) | Composicion farmaceutica que comprende polipeptidos del factor vii y polipeptidos del factor v. | |
| TW200637603A (en) | Oral treatment compositions containing anti-adhesion agent, antibacterial agent and incompatible compound | |
| GR1004016B (el) | Αναβραζοντα δισκια, που περιεχουν ως δραστικο συστατικο συμπλοκες ενωσεις σιδηρου, για την θεραπεια των σιδηροπενικων αναιμιων | |
| MY150767A (en) | Polyethylene glycol modifications of thymosin alpha 1 | |
| NO20021429L (no) | 1,4-dioksacykloalkan-2-oner og 1,4-dioksacykloalken-2-oner | |
| DE60212424D1 (de) | Radiopharmazeutishes mittel zur behandlung von krebs im frühstadium |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8332 | No legal effect for de |